• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ω-6脂质途径改变与早期囊性纤维化肺病中的中性粒细胞浸润和肺结构损伤相关。

The Omega-6 Lipid pathway shift is associated with neutrophil influx and structural lung damage in early cystic fibrosis lung disease.

作者信息

Slimmen Lisa Jm, Broos Jelle Y, Manaï Badies Han, Estevão Silvia C, Giera Martin, Kooij Gijs, Unger Wendy Wj, Janssens Hettie M

机构信息

Division of Respiratory Medicine and Allergology, Department of Paediatrics Erasmus MC Sophia Children's Hospital, Erasmus University Medical Centre Rotterdam The Netherlands.

Laboratory of Paediatrics, Infection and Immunity Group, Department of Paediatrics Erasmus University Medical Centre Rotterdam The Netherlands.

出版信息

Clin Transl Immunology. 2024 Sep 16;13(9):e70000. doi: 10.1002/cti2.70000. eCollection 2024 Sep.

DOI:10.1002/cti2.70000
PMID:39286529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403467/
Abstract

OBJECTIVES

In cystic fibrosis (CF), an imbalanced lipid metabolism is associated with lung inflammation. Little is known about the role that specific lipid mediators (LMs) exert in CF lung inflammation, and whether their levels change during early disease progression. Therefore, we measured airway LM profiles of young CF patients, correlating these with disease-associated parameters.

METHODS

Levels of omega (ω)-3/6 PUFAs and their LM derivatives were determined in bronchoalveolar lavage fluid (BALF) of children with CF ages 1-5 using a targeted high-performance liquid chromatography-tandem mass spectrometry approach. Hierarchical clustering analysis was performed on relative LM levels. Individual relative LM levels were correlated with neutrophilic inflammation (BALF %Neu) and structural lung damage (PRAGMA-CF %Disease). Significant correlations were included in a backward multivariate linear regression model to identify the LMs that are best related to disease progression.

RESULTS

A total of 65 BALF samples were analysed for ω-3/6 lipid content. LM profiles clustered into an arachidonic acid (AA)-enriched and a linoleic acid (LA)-enriched sample cluster. AA derivatives like 17-OH-DH-HETE, 5-HETE, 5,15-diHETE, 15-HETE, 15-KETE, LTB and 6-trans-LTB positively correlated with BALF %Neu and/or PRAGMA %Dis. Contrastingly, 9-HoTrE and the LA derivatives 9-HoDE, 9(10)-EpOME, 9(10)-DiHOME, 13-HoDE, 13-oxoODE and 12(13)-EpOME negatively correlated with BALF %Neu and/or PRAGMA %Dis. 6-trans-LTB was the strongest predictor for BALF %Neu. 5-HETE and 15-KETE contributed most to PRAGMA %Dis prediction.

CONCLUSIONS

Our data provide more insight into the lung lipidome of infants with CF, and show that a shift from LA derivatives to AA derivatives in BALF associates with early CF lung disease progression.

摘要

目的

在囊性纤维化(CF)中,脂质代谢失衡与肺部炎症相关。关于特定脂质介质(LMs)在CF肺部炎症中所起的作用,以及它们在疾病早期进展过程中水平是否发生变化,目前知之甚少。因此,我们测量了年轻CF患者的气道LM谱,并将其与疾病相关参数进行关联。

方法

采用靶向高效液相色谱-串联质谱法,测定1至5岁CF儿童支气管肺泡灌洗液(BALF)中ω-3/6多不饱和脂肪酸(PUFAs)及其LM衍生物的水平。对相对LM水平进行层次聚类分析。个体相对LM水平与中性粒细胞炎症(BALF中中性粒细胞百分比)和肺部结构损伤(PRAGMA-CF疾病百分比)相关。显著相关性纳入反向多变量线性回归模型,以确定与疾病进展最相关的LMs。

结果

共分析了65份BALF样本的ω-3/6脂质含量。LM谱聚类为富含花生四烯酸(AA)和富含亚油酸(LA)的样本簇。AA衍生物如17-OH-DH-HETE、5-HETE、5,15-二HETE、15-HETE、15-KETE、LTB和6-反式-LTB与BALF中中性粒细胞百分比和/或PRAGMA疾病百分比呈正相关。相反,9-HoTrE和LA衍生物9-HoDE、9(10)-EpOME、9(10)-DiHOME、13-HoDE、13-氧代ODE和12(13)-EpOME与BALF中中性粒细胞百分比和/或PRAGMA疾病百分比呈负相关。6-反式-LTB是BALF中中性粒细胞百分比的最强预测因子。5-HETE和15-KETE对PRAGMA疾病百分比预测贡献最大。

结论

我们的数据为CF婴儿的肺脂质组提供了更多见解,并表明BALF中从LA衍生物向AA衍生物的转变与CF肺部疾病早期进展相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/45db774b5d66/CTI2-13-e70000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/108b556305fe/CTI2-13-e70000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/48cb33d8af51/CTI2-13-e70000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/e8f79883b2f6/CTI2-13-e70000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/45db774b5d66/CTI2-13-e70000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/108b556305fe/CTI2-13-e70000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/48cb33d8af51/CTI2-13-e70000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/e8f79883b2f6/CTI2-13-e70000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11403467/45db774b5d66/CTI2-13-e70000-g005.jpg

相似文献

1
The Omega-6 Lipid pathway shift is associated with neutrophil influx and structural lung damage in early cystic fibrosis lung disease.ω-6脂质途径改变与早期囊性纤维化肺病中的中性粒细胞浸润和肺结构损伤相关。
Clin Transl Immunology. 2024 Sep 16;13(9):e70000. doi: 10.1002/cti2.70000. eCollection 2024 Sep.
2
Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.髓过氧化物酶氧化蛋氨酸与早期囊性纤维化肺病有关。
Eur Respir J. 2018 Oct 10;52(4). doi: 10.1183/13993003.01118-2018. Print 2018 Oct.
3
Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis.生物活性脂质的气道特征可预测囊性纤维化肺病的早期进展。
J Cyst Fibros. 2020 Nov;19(6):902-909. doi: 10.1016/j.jcf.2020.01.010. Epub 2020 Feb 10.
4
Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis.检测支气管肺泡灌洗液中的胆汁酸可定义囊性纤维化婴儿下呼吸道的炎症和微生物特征。
Microbiome. 2023 Jun 13;11(1):132. doi: 10.1186/s40168-023-01543-9.
5
Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.气道巨噬细胞在早期囊性纤维化肺病中表现出介导和调节清除作用的受体表达降低。
Front Immunol. 2023 Jun 29;14:1202009. doi: 10.3389/fimmu.2023.1202009. eCollection 2023.
6
Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.早期囊性纤维化肺病中的氧化应激和异常生物活性脂质。
J Cyst Fibros. 2019 Nov;18(6):781-789. doi: 10.1016/j.jcf.2019.04.011. Epub 2019 Apr 26.
7
Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.代谢组学分析成人囊性纤维化患者痰中调节性脂质介质。
Free Radic Biol Med. 2012 Jul 1;53(1):160-71. doi: 10.1016/j.freeradbiomed.2012.05.001. Epub 2012 May 8.
8
Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.从患有囊性纤维化的婴儿获取的支气管肺泡灌洗 fluid 中 DNA 水平升高。 (注:原文中“bronchoalveolar lavage fluid”表述不太准确,可能是“bronchoalveolar lavage fluid”,意为支气管肺泡灌洗 液 )
Am J Respir Crit Care Med. 1996 Nov;154(5):1426-9. doi: 10.1164/ajrccm.154.5.8912759.
9
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.巨噬细胞程序性死亡蛋白1与早期囊性纤维化气道疾病中的嗜中性粒细胞增多及细菌杀伤能力降低有关。
J Cyst Fibros. 2022 Nov;21(6):967-976. doi: 10.1016/j.jcf.2022.06.001. Epub 2022 Jun 19.
10
Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF.支气管肺泡灌洗中的关键炎症标志物可预测囊性纤维化幼儿的支气管扩张进展。
J Cyst Fibros. 2024 May;23(3):450-456. doi: 10.1016/j.jcf.2024.01.002. Epub 2024 Jan 20.

引用本文的文献

1
Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?囊性纤维化中的脂肪酸异常——治愈的关键环节缺失?
iScience. 2024 Oct 11;27(11):111153. doi: 10.1016/j.isci.2024.111153. eCollection 2024 Nov 15.

本文引用的文献

1
Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.气道巨噬细胞在早期囊性纤维化肺病中表现出介导和调节清除作用的受体表达降低。
Front Immunol. 2023 Jun 29;14:1202009. doi: 10.3389/fimmu.2023.1202009. eCollection 2023.
2
Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis.花生四烯酸衍生的脂质介质与复发性进展性多发性硬化症患者疾病严重程度的关系。
Neurology. 2023 Aug 1;101(5):e533-e545. doi: 10.1212/WNL.0000000000207459. Epub 2023 Jun 8.
3
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.
巨噬细胞程序性死亡蛋白1与早期囊性纤维化气道疾病中的嗜中性粒细胞增多及细菌杀伤能力降低有关。
J Cyst Fibros. 2022 Nov;21(6):967-976. doi: 10.1016/j.jcf.2022.06.001. Epub 2022 Jun 19.
4
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.依列卡福妥联合替扎卡福妥和依伐卡托对比替扎卡福妥联合依伐卡托治疗F508del-CFTR纯合子囊性纤维化患者的疗效和安全性:一项为期24周的多中心、随机、双盲、活性对照3b期试验
Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20.
5
Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis.Lumacaftor-Ivacaftor 对肺清除指数、磁共振成像和 Phe508del 纯合子囊性纤维化患者气道微生物组的影响。
Ann Am Thorac Soc. 2021 Jun;18(6):971-980. doi: 10.1513/AnnalsATS.202008-1054OC.
6
The Resolution Approach to Cystic Fibrosis Inflammation.囊性纤维化炎症的解决方法
Front Pharmacol. 2020 Jul 29;11:1129. doi: 10.3389/fphar.2020.01129. eCollection 2020.
7
Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.囊性纤维化中异常的 n-6 脂肪酸代谢导致肺部症状。
Prostaglandins Leukot Essent Fatty Acids. 2020 Sep;160:102156. doi: 10.1016/j.plefa.2020.102156. Epub 2020 Jun 26.
8
Systematic Evaluation of Normalization Methods for Glycomics Data Based on Performance of Network Inference.基于网络推理性能的糖组学数据标准化方法的系统评估
Metabolites. 2020 Jul 2;10(7):271. doi: 10.3390/metabo10070271.
9
The role of the LTB4-BLT1 axis in health and disease.LTB4-BLT1 轴在健康和疾病中的作用。
Pharmacol Res. 2020 Aug;158:104857. doi: 10.1016/j.phrs.2020.104857. Epub 2020 May 18.
10
The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide.必需脂肪酸在囊性纤维化中的作用和芬维 A 酯的正常化效应。
Cell Mol Life Sci. 2020 Nov;77(21):4255-4267. doi: 10.1007/s00018-020-03530-x. Epub 2020 May 11.